N-Acetyl Semax Amidate: What Research Shows

Research reference · Updated October 2026 · ~7 min read

N-Acetyl Semax Amidate is a terminally modified form of Semax, a synthetic heptapeptide studied for cognition and neuroprotection. Catalogs often shorten the name to NASA. The core sequence stays the same. An acetyl group on the N-terminus and an amide on the C-terminus are added to slow enzymatic breakdown. The clinical record belongs almost entirely to unmodified Semax. This page is research information only, not a protocol for human use.

Where the sequence comes from

Semax was developed at the Institute of Molecular Genetics in Moscow as an analog of ACTH(4-10), not as a copy of that fragment. ACTH(4-10) is Met-Glu-His-Phe-Arg-Trp-Gly. Semax keeps the Met-Glu-His-Phe start and replaces the rest with Pro-Gly-Pro, giving Met-Glu-His-Phe-Pro-Gly-Pro. That tail resists cleavage better than the native ACTH ending. Unlike full-length ACTH, Semax does not drive adrenal steroid release. Researchers study it for attention, memory, and recovery after ischemic injury.

N-Acetyl Semax Amidate is the same heptapeptide written as Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2. The Semax protocol page lists the parent peptide at about 813 daltons, water soluble, stored lyophilized near -20 C. The two caps shift the mass slightly. They are the only reason NASA is catalogued as its own material.

What the two caps are supposed to do

Short peptides in solution are trimmed from the ends. Aminopeptidases remove residues from the N-terminus. Carboxypeptidases work from the C-terminus. N-acetylation blocks the first route. C-terminal amidation blocks the second. Chemists use both caps when they want a longer intact window after mixing. The Pro-Gly-Pro tail already helped Semax. NASA adds a second layer of end protection.

That is standard peptide chemistry, not proof that NASA is stronger or safer. Head-to-head trials of half-life, BDNF response, or cognitive scores for N-Acetyl Semax Amidate versus Semax are not in the mainstream literature. Treating NASA as a proven upgrade overstates the record.

FeatureSemaxN-Acetyl Semax Amidate
SequenceMet-Glu-His-Phe-Pro-Gly-ProSame core, N-acetyl and C-amide
Main evidenceRodent studies and Russian clinical reportsChemical rationale, little direct clinical data
Common research formIntranasal solution (0.1% and 1% in Russian product literature)Lyophilized powder for laboratory reconstitution
Regulatory statusNot FDA-approved. Local clinical use in RussiaResearch compound only. No FDA approval

The comparison is descriptive. It is not a dosing chart and it is not a recommendation to administer either compound.

What studies on Semax actually report

Almost every biological claim attached to NASA is borrowed from the parent peptide. Those findings are real, and they have limits.

Do not transfer dose figures across analogs. Research summaries of Semax often cite an intranasal range around 200 to 600 mcg per day, split across the day. Those figures are research-reported context for the parent peptide. They are not a NASA dose, and they are not advice. See the Semax protocol for the source notes, and keep the two materials labeled separately in any lab record.

Handling a lyophilized research vial

NASA is usually supplied as a dry powder. Concentration depends on the stated milligrams in the vial and the diluent volume. Use the reconstitution calculator and the steps in how to reconstitute peptides before writing a protocol. Semax is water soluble. Bacteriostatic water is the usual diluent for injectable research preparations. Sterile saline is the usual diluent for an intranasal solution of the parent peptide.

Keep lyophilized vials cold, dry, and out of light. After reconstitution, refrigerate and use the solution within a short research window. Repeated freeze-thaw cycles damage most peptides of this size. The protocols index collects the same handling pattern for other research sequences.

How it differs from Selank

Selank is the other Russian heptapeptide that sits next to Semax in research catalogs. It is a tuftsin analog, not an ACTH fragment. Its literature leans toward anxiety models and GABAergic tone. Semax literature leans toward neurotrophins, monoamines, and ischemia. They are not substitutes. Research-reported Selank figures are on the Selank peptide dose page, with notes on the Selank protocol.

What is not established

There is no robust long-term safety database for N-Acetyl Semax Amidate. Drug interactions, pregnancy, and outcomes in psychiatric or neurological illness are unknown. Intranasal Semax reports mention nasal irritation most often. Restlessness or shorter sleep is sometimes described with late-day exposure. Those notes come from Semax experience and informal logs, not from a controlled NASA safety program.

Purity is a separate variable. Short custom peptides vary in HPLC purity and residual solvents. An unexpected result can come from impurities rather than the sequence. Prefer lots with a current certificate of analysis, and compare tested vendors on the supplier list.

Terminal caps should slow exopeptidases. That does not mean NASA has been shown to reproduce Semax findings at a known exposure. Cite Semax papers as Semax papers, and describe NASA as a modified research analog with a plausible stability rationale.

Convert vial mass to a research concentration

Open the Calculator →
⚠️ RESEARCH USE ONLY: This content is for educational and research purposes only. Peptides discussed are not approved for human consumption. Nothing here is medical advice. Consult qualified professionals.